MUMBAI: Nobel Biocare is known as a renowned leader in implant-based dental restorations which has recently informed its plans to further consolidate its efforts in the country. The main objective behind the amalgamation is to strengthen its role in the Indian market. By these steps, the company plans to support its increasing customer base in India.
Richard T Laube, CEO Nobel Biocare and Michael Glenn Thompson head of Asia Pacific are planning to meet with foremost clinicians and other representatives from the Indian dental community. The major reason behind the initiative is to reaffirm the company’s assurance to India and draw their plans for growth within the country.
CEO of the company informed that since India is a very attractive dental market that is expected to grow substantially over the next years and Nobel Biocare will continue partnering with Indian clinicians to help patients achieve improved quality of life. Richard added “India has seen a shift in dental implants becoming the preferred treatment for missing teeth. Patient awareness is also on the rise with more opting in favor of fixed implant-based solutions versus conventional removable options. With a full offering of products and solutions to meet this demand, Nobel Biocare can support customers of varying skill levels from beginner to expert throughout the entire treatment workflow.”